百利天恒股价跌至324.21元 成都本土企业市值首现"双千亿"

Group 1 - The stock price of Baili Tianheng closed at 324.21 yuan on August 27, 2025, down by 15.79 yuan, a decrease of 4.64% from the previous trading day [1] - The company operates in the pharmaceutical and biotechnology industry, focusing on innovative drug development, particularly in the field of biopharmaceuticals [1] - Baili Tianheng has successfully developed 8 innovative ADC drugs that are currently in clinical stages, which target cancer cells to enhance treatment efficacy [1] Group 2 - Baili Tianheng and a local company, Xinyi Sheng, have set a new market capitalization record for Chengdu, with respective market values of 136.34 billion yuan and 280.27 billion yuan, achieving a "double hundred billion" market cap for Chengdu-listed companies [1] - The actual controller of the company, Zhu Yi, has a shareholding value of 101.32 billion yuan [1] - On August 27, the net inflow of main funds into Baili Tianheng was 211,600 yuan, with a cumulative net inflow of 6.7755 million yuan over the past five days [1]